Back to search

Article

CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy

2025-04-28

Abstract excerpt

Abstract Immuno‐oncology represents an emerging field that has significantly transformed tumor therapeutics, with immune cells serving as the cellular foundations of cancer immunotherapy. Due to its high efficiency and sensitivity, CRISPR/Cas9 genome editing is a highly promising technique for precise and rapid gene modification. This review provides an overview of recent advancements in the application of CRISPR/...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e291cce5-00d6-596c-b32d-175763228897
DOI
10.1002/viw.20250002
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapyDOI 10.1002/viw.20250002
Select a neighboring publication to make it the new centre.